SANEGENE BIO
SANEGENE BIO
Industry:
Biopharma Health Care Medical
Founded:
2021-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Status:
Active
Total Funding:
38 M USD
Similar Organizations
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
SmartPharm Therapeutics
SmartPharm Therapeutics is a second-generation gene-encoded therapeutics company.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Investors List
Qiming Venture Partners
Qiming Venture Partners investment in Series A - Sanegene Bio
More informations about "Sanegene Bio"
Sanegene Bio - Crunchbase Company Profile & Funding
When was the last funding round for Sanegene Bio? Sanegene Bio closed its last funding round on Dec 1, 2023 from a Series A round. Who are Sanegene Bio 's competitors? Alternatives and possible competitors to Sanegene Bio may …See details»
About Us - SanegeneBio
SanegeneBio is an emerging RNAi-based company developing innovative RNA interference (RNAi) therapeutics driven by the cutting-edge delivery technology.See details»
Sanegene Bio Company Profile 2024: Valuation, …
Sanegene Bio General Information Description. Developer of RNA interference (RNAi) therapeutics designed to knock down disease-causing genes. The company's products are constructed and developed with RNA technology and …See details»
Sanegene Bio - LinkedIn
Sanegene Bio | 376 followers on LinkedIn. Dedicated to developing novel life-changing RNAi therapeutics | SanegeneBio is an emerging RNAi-based company developing innovative RNA interference (RNAi ...See details»
Sanegene Bio - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Sanegene Bio (Suzhou) Co., Ltd.
Jul 8, 2023 Explore Sanegene Bio (Suzhou) Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, 3 news, Disease Domain:Endocrinology and Metabolic …See details»
Sanegene Bio Usa, Inc. - Drug pipelines, Patents, Clinical trials
Explore Sanegene Bio Usa, Inc. with its drug pipeline, therapeutic area, technology platform, 3 news, Technology Platform:siRNA, Drug:DSGB-3908, SGB-3908. Biomedical products. ... The …See details»
Science & Pipeline - SanegeneBio
A Robust Drug Discovery Platform Has Been Established to Develop Novel, Potent and Safe RNAi TherapeuticsSee details»
Sanegene Bio - Crunchbase
Organization. Sanegene Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies …See details»
Sanegene Bio Company Profile: Overview and Full News Analysis
Sanegene Bio has also secured significant funding, with nearly $100 million raised in Series A+ financing led by Tencent Investment and Yuanbio Venture Capital. Notably, Sanegene Bio …See details»
SanegeneBio - Work in biotech
SanegeneBio is developing RNA interference (RNAi) therapeutics for unmet clinical needs. RNAi triggers the gene silencing to reduce the protein production of specific targets by leveraging an …See details»
Science & Pipeline - SanegeneBio
Sanegene' s RNAi-based therapeutics have achieved effective and durable impacts to silence the target genes specifically in different organs. RNAi Therapeutics RNA molecules exhibit unique …See details»
Sanegene Bio - Updates, News, Events, Signals & Triggers
Sanegene Bio may be growing as it has entered into a strategic collaboration to develop an siRNA drug for the treatment of hypertension, indicating an expansion of its research and …See details»
Innovent and SanegeneBio Enter Strategic Collaboration to …
Dec 27, 2023 Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality …See details»
SanegeneBio and Orbit join forces to establish targeting peptides
Jan 5, 2023 Through the collaboration with Orbit, Sanegene is looking to develop a portfolio of advanced RNAi therapeutics. Orbit’s technology enables the screening of large quantities of …See details»
Investors & Partners - SanegeneBio
We Proactively Seek and Drive Partnership Opportunities to Strengthen the First-mover Advantage of Our PipelineSee details»
Series A - Sanegene Bio - 2022-11-29 - Crunchbase
Nov 29, 2022 Organization Name . Sanegene Bio . Announced Date Nov 29, 2022; Funding Type Series A; Funding Stage Early Stage Venture; Lead Investors. Edit Lead Investors …See details»
Innovent and Sanegenebio to co-develop AGT-targeting siRNA …
Dec 27, 2023 Innovent Biologics Inc. and Sanegene Bio USA Inc. (Sanegenebio) have announced they have entered into a collaboration agreement to co-develop SGB-3908, an …See details»
Series A - Sanegene Bio - 2021-09-01 - Crunchbase
Sanegene Bio raised $38000000 on 2021-09-01 in Series A. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. Funding …See details»